くすりのしおり

Injection
Revised: 6/2015

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
EDARAVONE I.V. DRIP INFUSION BAG 30mg "DSEP"
 Active ingredient:
Edaravone
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine protects brain by scavenging free radicals which increase in region with poor blood flow.
It is usually used to improve neurological symptoms associated with cerebral infarction and performance impairment or functional disorder in daily life.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have renal disorder, hepatic disorder, heart disorder or infectious disease.
    If you are depressed consciousness or impaired mind.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, administer intravenously with an infusion over 30 minutes twice a day.
    The treatment span will be determined while watching your symptoms, but not exceeded 14 days.

Precautions while taking this medicine

  • You will be received blood tests frequently for checking your renal, hepatic and blood function, the number of times depends on your symptoms.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include feeling of warmth and elevation of blood pressure. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • decreased urine output, swelling, headache [acute renal failure, nephrotic syndrome]
  • loss of appetite, malaise, vomiting [severe hepatitis, impaired liver function, jaundice]
  • fever, malaise, bleeding tendency (nose/gum/subcutaneous bleeding, etc.) [thrombocytopenia, granulocytopenia, disseminated intravascular coagulation]
  • reddish brown urine, muscle pain, feeling of weakness [rhabdomyolysis]
  • rash, respiratory distress, dizziness on standing up [shock, anaphylaxis]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z